The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating biomarkers and outcomes in advanced non-small cell lung cancer patients treated with anti-PD1 (program death 1 receptor) monoclonal antibodies.
 
Mary J. Fidler
Consulting or Advisory Role - Abbvie; Abbvie (I); AstraZeneca; Bristol-Myers Squibb; Celgene; Genentech (I)
Speakers' Bureau - Celgene; Genentech; Merck
 
Marta Batus
No Relationships to Disclose
 
Imad Tarhoni
No Relationships to Disclose
 
Selina Sayidine
No Relationships to Disclose
 
Cristina L. Fhied
No Relationships to Disclose
 
Sanjib Basu
No Relationships to Disclose
 
Philip Bonomi
Honoraria - AstraZeneca; Biodesix; Bristol-Myers Squibb; Lilly; Merck; pfizer; Roche/Genentech; Trovagene
Consulting or Advisory Role - AstraZeneca; Biodesix; Bristol-Myers Squibb; Lilly; Merck; Merck; Pfizer; Roche/Genentech; Trovagene
Research Funding - AstraZeneca (Inst); Biodesix (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - No disclosures
Expert Testimony - No disclosures
Travel, Accommodations, Expenses - No disclosures
Other Relationship - No disclosures
 
Jeffrey Allen Borgia
Consulting or Advisory Role - EMD Millipore